“The Russian Ministry of Health has re-registered the drug with the trade name Frisium,” the press service said.
The Ministry of Health clarified that the registration certificate was issued on August 24.
The ministry recalled that Frisium had been allowed in Russia for over 20 years, but the term of the previous registration certificate had expired.
The press service explained that “taking into account the overall current, acute need for the availability of the drug Frisium registered in Russia, the Ministry of Health of Russia has used all available resources to reduce all stages of passing the dossier documents and conduct appropriate examinations in order to register as soon as possible for the drug "Frisium" without violating the law ".
Earlier it was reported that the Ministry of Health of Russia issued a registration certificate for the drug "Levilimab" (trade name "Ilsira") for the treatment of patients with coronavirus infection COVID-19.